Understanding respiratory tract infections through minimally-invasive, daily nasal sampling in children
This project aims to elucidate the immune and microbiota factors influencing upper respiratory tract infections in children through innovative nasal sampling and multi-omics analyses, enhancing diagnostics and public health strategies.
Projectdetails
Introduction
Pneumonia is the number one infectious cause of death in children worldwide. Many of the viruses and bacteria that cause pneumonia regularly infect, or colonize, the upper respiratory tract (URT) without causing disease. This drives community transmission but is also an important source of immunity. The processes and key host immune and microbiota factors that determine the infection kinetics, transmission, and development of immunity during such infections need elucidation.
Methodology
I have recently optimized minimally-invasive nasal sampling analysis methods using Synthetic Absorptive Matrix (SAM) strips that now allow me to address these knowledge gaps. Through the daily collection of such well-tolerated nasal samples in children, I will study:
- Non-pathological, naturally-acquired URT infections.
- Controlled infections in an ethical and safe manner using the live attenuated influenza vaccine.
In addition, I will perform high-frequency nasal sampling in groups of schoolchildren to precisely measure transmission events over time and even infer exposure.
Data Collection
Incoming bacteria, viruses, and the resident URT microbiome, as well as mucosal host innate and adaptive immune responses, will be quantified in parallel throughout infections using existing and new high-throughput assays, including:
- An antigen array.
- Microfluidic qPCR for 32 pathogens.
Analysis
Multi-omics integrative time-series analyses and mathematical modeling will be used to identify parameters that are central and predictive for:
- Pathogen acquisition.
- Replication and clearance.
- Transmission and immune boosting.
Key novel markers and concepts will be validated using state-of-the-art in vitro mucosal models.
Impact
The comprehensive and detailed understanding of URT infections obtained in this project can lead to better diagnostics, mucosal targeted therapies, and vaccines. It will also provide a basis for the improved predictions of pathogen spread and public health effects of interventions at the population level.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.677.858 |
Totale projectbegroting | € 1.677.858 |
Tijdlijn
Startdatum | 1-7-2023 |
Einddatum | 30-6-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- ACADEMISCH ZIEKENHUIS LEIDENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Dynamics and heterogeneity of early viral infectionThis project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Reversing vaccine hypo-responsivenessThe project aims to understand and reverse vaccine hypo-responsiveness across populations by investigating immunological and metabolic factors, ultimately improving vaccine efficacy globally. | ERC Advanced... | € 2.372.681 | 2022 | Details |
Deciphering the antibody-microbiota axis in early lifeThis project aims to explore how early life immune exposures shape immunoglobulin repertoires and their impact on health, particularly allergies, by analyzing B cell receptor sequences and microbiota antigens. | ERC Starting... | € 1.650.000 | 2023 | Details |
Questioning the Epidemiology of Subclinical TuberculosisThe TB-QUEST study aims to investigate the transmission potential of subclinical TB using genome sequencing and wearable technology, challenging current definitions and screening methods. | ERC Starting... | € 2.499.700 | 2024 | Details |
Human genetic determinants of invasive group A streptococcal host-pathogen interactionsThis project aims to identify genetic factors that increase susceptibility to invasive Group A streptococcus infections by integrating human genetics with host-pathogen interaction studies. | ERC Starting... | € 1.496.978 | 2025 | Details |
Dynamics and heterogeneity of early viral infection
This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.
Reversing vaccine hypo-responsiveness
The project aims to understand and reverse vaccine hypo-responsiveness across populations by investigating immunological and metabolic factors, ultimately improving vaccine efficacy globally.
Deciphering the antibody-microbiota axis in early life
This project aims to explore how early life immune exposures shape immunoglobulin repertoires and their impact on health, particularly allergies, by analyzing B cell receptor sequences and microbiota antigens.
Questioning the Epidemiology of Subclinical Tuberculosis
The TB-QUEST study aims to investigate the transmission potential of subclinical TB using genome sequencing and wearable technology, challenging current definitions and screening methods.
Human genetic determinants of invasive group A streptococcal host-pathogen interactions
This project aims to identify genetic factors that increase susceptibility to invasive Group A streptococcus infections by integrating human genetics with host-pathogen interaction studies.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Development and validation of a universal bacterial diagnostics test to detect the respiratory microbiome and pathogenic disturbances therein for routine microbial laboratoriesEr is geen beschikbare samenvatting van het project. | Mkb-innovati... | € 149.940 | 2013 | Details |
Development and validation of a universal bacterial diagnostics test to detect the respiratory microbiome and pathogenic disturbances therein for routine microbial laboratories
Er is geen beschikbare samenvatting van het project.